Brief: Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador
27/05/2026 08:30
BRIEF-Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador May 27 (Reuters) - Synthaverse SA SVEP.WA:
RECEIVES MARKETING AUTHORIZATION FOR ONKO BCG MEDICINAL PRODUCT IN ECUADOR
Source text: ID:nEM7CGqwHa
Further company coverage: SVEP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility